Adverum Biotech
Tommy T. is a professional with years of experience in the biotechnology industry. Currently serving as the Quality Control Lab Operations Manager at Adverum Biotechnologies, Tommy previously held the role of Associate Scientist at Alector. With a background as a Senior Research Associate at BioMarin Pharmaceutical Inc. and experience as a Quality Control Chemist at Bio-Rad Laboratories, Tommy's career has been focused on ensuring quality and efficiency in laboratory operations. Tommy holds certificates in Supply Management and Project Management from UC San Diego.
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.